Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027318	s-etglygc	— (—)	90	97	100.00%	Distribution not available
3027318	s-etglygc	mmol/l (mmol/l)	36	37	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

43.46

133.21

1.1

1.0

—

mmol/l

—

42.89

131.68

1.1

1.0

—

mmol/l

—

Substance abuse

36.58

130.41

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to psychoactive substance use

34.95

129.09

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol

39.03

128.09

1.1

1.0

—

mmol/l

—

Substance abuse, excluding more controls

46.05

128.06

1.1

1.0

—

mmol/l

—

Alcohol use disorder, Swedish definition

41.88

126.99

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

41.19

122.54

1.2

1.0

—

mmol/l

—

Alcohol use disorder, ICD-based

39.57

116.49

1.2

1.0

—

mmol/l

—

Alcohol dependence

47.46

88.82

1.2

1.0

—

mmol/l

—

Acute alcohol intoxication

48.18

82.20

1.2

1.0

—

mmol/l

—

Persons encountering health services in other circumstances

28.38

75.81

1.2

1.0

—

mmol/l

—

Acute alcohol intoxication, ICD10

34.78

71.10

1.2

1.0

—

mmol/l

—

Poisoning by medicine

31.66

62.99

1.2

—

mmol/l

—

Poisoning by drugs, medicaments and biological substances

25.71

58.84

1.2

1.1

—

mmol/l

—

Mood disorders, excluding more controls

19.62

52.85

1.1

1.0

—

mmol/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

29.29

52.39

1.3

1.0

—

mmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

21.48

52.29

1.1

1.2

—

mmol/l

—

Suicide or other Intentional self-harm

20.62

48.69

1.3

1.0

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

18.14

47.27

1.3

1.0

—

mmol/l

—

Benzodiazepine use

8.42

42.64

1.1

—

mmol/l

—

Any mental disorder

14.08

41.17

1.2

1.0

—

mmol/l

—

Psychiatric diseases

14.03

39.03

1.2

1.0

—

mmol/l

—

Other antidepressants

10.10

36.79

1.1

—

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

8.20

34.51

1.2

1.0

—

mmol/l

—

Depression

7.54

34.50

1.2

1.1

—

mmol/l

—

Implicit Sepsis

8.29

33.30

1.2

1.1

—

mmol/l

—

Mood [affective] disorders

7.05

33.10

1.2

1.1

—

mmol/l

—

Specific personality disorders

15.30

33.09

1.2

—

mmol/l

—

Mood disorders

7.04

33.04

1.2

1.1

—

mmol/l

—

Disorders of adult personality and behaviour

12.33

32.35

1.2

1.1

—

mmol/l

—

Open wound of head

9.61

32.33

1.2

1.1

—

mmol/l

—

Acute renal failure

19.28

31.81

1.0

1.2

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

47.59

31.49

1.3

1.0

—

mmol/l

—

Personality disorders

12.43

31.48

1.2

1.1

—

mmol/l

—

Anxiety disorders, excluding more controls

14.92

31.34

1.3

1.0

—

mmol/l

—

Anxiety (asthma-related co-morbidities)

16.91

30.94

1.3

1.0

—

mmol/l

—

Alcohol abuse, main dg

42.41

30.84

1.2

1.0

—

mmol/l

—

Intracranial trauma

10.93

30.39

1.2

1.1

—

mmol/l

—

Concussion

11.33

30.18

1.2

1.1

—

mmol/l

—

Exposure to unspecified factor

6.37

30.13

1.1

—

mmol/l

—

Implicit bacterial Sepsis

12.37

29.94

1.1

—

mmol/l

—

Bacterial Sepsis

10.96

28.24

1.1

—

mmol/l

—

Selective serotonin reuptake inhibitors

8.39

28.21

1.1

—

mmol/l

—

Persons encountering health services in other circumstances, wide

6.31

27.67

1.2

1.0

—

mmol/l

—

Fall on same level

6.21

27.47

1.2

1.1

—

mmol/l

—

Depression or dysthymia

17.92

26.52

1.1

1.0

—

mmol/l

—

Substance use, excluding alcohol

45.84

26.44

1.2

1.0

—

mmol/l

—

Injuries to the head

5.89

26.39

1.1

1.0

—

mmol/l

—

Intracranial injury

7.57

25.22

1.2

1.1

—

mmol/l

—

Personality disorders, excluding more controls

34.52

24.22

1.2

1.0

—

mmol/l

—

Schizophrenia or delusion

8.80

23.27

1.1

1.2

—

mmol/l

—

Schizophrenia, schizotypal and delusional disorders

8.80

23.27

1.1

1.2

—

mmol/l

—

Schizophrenia or delusion, excluding more controls

36.03

22.85

1.1

1.0

—

mmol/l

—

Falls/tendency to fall

6.39

22.59

1.1

—

mmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

9.27

20.84

1.3

1.1

—

mmol/l

—

Use of hypnotics and sedatives

5.16

19.77

1.2

1.0

—

mmol/l

—

Other anxiety disorders

7.53

18.82

1.3

1.0

—

mmol/l

—

Metabolic disorders

5.36

18.66

1.1

—

mmol/l

—

Unspecified mental disorder

6.84

18.21

1.1

1.2

—

mmol/l

—

Use of disulfiram, acamprosate or naltrexone

33.05

17.95

1.2

1.0

—

mmol/l

—

Renal failure

7.26

17.85

1.0

1.2

—

mmol/l

—

Invasive ventilation

42.26

17.28

1.0

—

mmol/l

—

Kela-code for severe mental illness

6.76

16.11

1.1

1.2

—

mmol/l

—

Renal tubulo-interstitial diseases

4.75

15.92

1.1

1.2

—

mmol/l

—

Malaise and fatigue

6.62

15.85

1.1

1.0

—

mmol/l

—

Convulsions, not elsewhere classified

9.89

15.56

1.1

1.0

—

mmol/l

—

Pneumonia, organism unspecified

4.49

15.40

1.1

—

mmol/l

—

Alcohol withdrawal state with delirium

28.77

15.18

1.2

1.0

—

mmol/l

—

Emotionally unstable personality disorder

28.66

15.17

1.3

1.1

—

mmol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.26

14.99

1.1

—

mmol/l

—

Influenza and pneumonia

4.11

14.67

1.1

—

mmol/l

—

All anxiety disorders

5.31

14.56

1.3

1.0

—

mmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

36.20

14.43

1.2

1.0

—

mmol/l

—

Other and unspecified effects of external causes

7.70

14.41

1.1

1.3

—

mmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

4.03

13.95

1.1

—

mmol/l

—

All pneumoniae

4.01

13.86

1.1

—

mmol/l

—

Non-selective monoamine reuptake inhibitors

9.17

13.81

1.1

1.2

—

mmol/l

—

Other bacterial diseases

4.19

13.63

1.1

—

mmol/l

—

Type of accident

7.61

13.55

1.3

1.1

—

mmol/l

—

4.55

13.35

1.1

—

mmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4.55

13.35

1.1

—

mmol/l

—

Other and unspecified nonorganic psychotic disorders

8.11

12.74

1.0

1.2

—

mmol/l

—

Epilepsy

7.02

12.64

1.0

1.2

—

mmol/l

—

Nausea and vomiting

8.29

12.11

1.1

1.2

—

mmol/l

—

Diseases of liver

6.01

12.11

1.0

1.2

—

mmol/l

—

Bleeding

4.27

12.09

1.1

—

mmol/l

—

Neurotic, stress-related and somatoform disorders

3.92

12.05

1.2

1.0

—

mmol/l

—

Acute pancreatitis

8.84

11.99

1.2

—

mmol/l

—

Anxiety disorders

3.90

11.99

1.2

1.0

—

mmol/l

—

Persons encountering health services for specific procedures, not carried out

30.13

11.64

1.1

1.0

—

mmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

18.95

11.57

1.4

1.0

—

mmol/l

—

Hypo-osmolality and hyponatraemia

18.87

11.55

1.1

1.0

—

mmol/l

—

Acute pancreatitis (for exclusion)

7.91

11.00

1.2

1.1

—

mmol/l

—

Other symptoms and signs involving cognitive functions and awareness

5.69

10.68

1.3

1.1

—

mmol/l

—

Other specified and unspecified personality disorders

21.50

10.67

1.2

1.1

—

mmol/l

—

Dental pulpitis 1, only avohilmo

3.73

10.65

1.2

1.1

—

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

6.00

10.37

1.2

—

mmol/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.26

10.26

1.1

—

mmol/l

—

Leisure time condition

8.68

10.23

1.5

1.1

—

mmol/l

—

Bipolar affective disorders

8.68

10.22

1.3

1.1

—

mmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

11.02

10.16

1.1

1.4

—

mmol/l

—

Lung diseases due to external agents

11.02

10.16

1.3

1.2

—

mmol/l

—

Recurrent or chronic depression

19.27

10.09

1.0

—

mmol/l

—

Hypokalaemia

16.72

9.86

1.1

—

mmol/l

—

Dental pulpitis 4, only avohilmo

3.57

9.84

1.2

1.1

—

mmol/l

—

Other and unspecified myopathies

26.09

9.81

1.1

1.0

—

mmol/l

—

Other reaction to severe stress, and adjustment disorders

6.40

9.80

1.2

1.0

—

mmol/l

—

General symptoms and signs

3.55

9.62

1.2

1.0

—

mmol/l

—

Diseases of the myoneural junction and muscle

17.55

9.39

1.1

1.0

—

mmol/l

—

severe traumatic brain injury, does not include concussion

7.01

9.28

1.1

1.2

—

mmol/l

—

Persistent mood disorders

9.18

8.97

1.1

—

mmol/l

—

Volume depletion

24.05

8.90

1.0

—

mmol/l

—

Dental pulpitis 1

3.46

8.73

1.1

—

mmol/l

—

Other external causes of accidental injury

5.24

8.73

1.3

1.0

—

mmol/l

—

Diseases of pulp and periapical tissues, including avohilmo

3.46

8.73

1.1

—

mmol/l

—

Dental pulpitis 4

3.40

8.51

1.1

—

mmol/l

—

Assault

7.51

8.41

1.0

1.3

—

mmol/l

—

Viral hepatitis, IBD co-morbidity

+∞

8.34

1.1

0.0

—

mmol/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.22

8.24

1.2

1.0

—

mmol/l

—

Insulin medication

3.95

8.24

1.2

1.1

—

mmol/l

—

Diabetes mellitus

3.21

8.23

1.1

—

mmol/l

—

Bacterial infection, other or unspecified

4.51

8.23

1.1

—

mmol/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.00

8.12

1.2

—

mmol/l

—

Accidents

5.01

8.02

1.3

1.0

—

mmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

22.02

8.00

1.2

1.0

—

mmol/l

—

Endocrine, nutritional and metabolic diseases

3.96

8.00

1.1

—

mmol/l

—

Certain infectious and parasitic diseases

3.41

7.97

1.3

1.0

—

mmol/l

—

Antihypertensive medication - note that there are other indications

4.63

7.73

1.1

—

mmol/l

—

Diabetes, varying definitions

3.12

7.71

1.1

—

mmol/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.69

7.70

1.2

1.1

—

mmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3.15

7.43

1.2

1.1

—

mmol/l

—

Infections of the skin and subcutaneous tissue

3.41

7.31

1.2

1.1

—

mmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

20.06

7.13

1.4

1.0

—

mmol/l

—

Insulin, intermediate and long-acting

3.66

7.10

1.2

1.1

—

mmol/l

—

Parasetamol

3.49

6.86

1.2

1.1

—

mmol/l

—

Asthma, unspecified (mode), excluding more controls

4.83

6.80

1.0

1.2

—

mmol/l

—

Cutaneous abscess, furuncle and carbuncle

5.42

6.76

1.2

—

mmol/l

—

Diseases of the digestive system

4.24

6.71

1.2

1.1

—

mmol/l

—

GI-bleeding

5.00

6.69

1.2

1.1

—

mmol/l

—

Explicit Sepsis

5.42

6.67

1.1

—

mmol/l

—

Neurological diseases, wide definition

9.42

6.59

1.1

1.0

—

mmol/l

—

External causes of morbidity and mortality

5.73

6.59

1.2

1.0

—

mmol/l

—

Type 1 diabetes

5.20

6.47

1.2

1.1

—

mmol/l

—

Other diseases of the digestive system

4.83

6.44

1.2

1.1

—

mmol/l

—

Nutritional anaemias

4.32

6.43

1.1

—

mmol/l

—

Aplastic and other anaemias

4.34

6.40

1.1

—

mmol/l

—

Pneumonitis due to solids and liquids

14.32

6.39

1.3

1.0

—

mmol/l

—

Other and unspecified anaemias

4.54

6.36

1.1

1.2

—

mmol/l

—

Other anaemias

4.52

6.34

1.1

1.2

—

mmol/l

—

Fall on and from stairs and steps

5.46

6.28

1.2

1.3

—

mmol/l

—

Alcohol-induced chronic pancreatitis

18.06

6.26

1.3

1.0

—

mmol/l

—

STROKE

4.00

6.23

1.1

—

mmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

2.80

6.20

1.2

1.1

—

mmol/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.13

6.15

1.1

1.0

—

mmol/l

—

Fracture of femur

5.48

6.11

1.2

1.1

—

mmol/l

—

Asthma, unspecified (mode)

4.37

6.11

1.0

1.2

—

mmol/l

—

Type 2 diabetes, wide definition

3.26

6.10

1.1

—

mmol/l

—

Alcoholic liver disease

12.53

6.08

1.0

1.3

—

mmol/l

—

Chronic pancreatitis

12.52

6.07

1.3

—

mmol/l

—

Organic, including symptomatic, mental disorders

4.23

6.06

1.1

—

mmol/l

—

Other septicaemia

4.91

6.05

1.1

1.2

—

mmol/l

—

Neurological diseases

3.11

6.03

1.1

—

mmol/l

—

Injuries to the wrist and hand

2.73

6.02

1.1

—

mmol/l

—

Persons encountering health services for specific procedures and health care

2.64

5.96

1.1

—

mmol/l

—

Other disorders of urethra and urinary system

3.50

5.93

1.1

—

mmol/l

—

Event of undetermined intent

15.04

5.90

1.1

1.0

—

mmol/l

—

Insulin, fast-acting

4.00

5.88

1.1

—

mmol/l

—

Type 2 diabetes

2.87

5.84

1.2

1.1

—

mmol/l

—

Traumatic subdural haemorrhage

14.77

5.84

1.1

1.3

—

mmol/l

—

COPD/asthma/ILD related infections

2.95

5.75

1.2

1.1

—

mmol/l

—

COPD/asthma related infections

2.95

5.75

1.2

1.1

—

mmol/l

—

Heart failure, not strict

3.08

5.70

1.1

1.2

—

mmol/l

—

Diabetes medication

2.70

5.65

1.2

1.1

—

mmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.59

5.64

1.0

1.3

—

mmol/l

—

Injuries to the thorax

3.53

5.59

1.2

1.1

—

mmol/l

—

Heart failure and antihypertensive medication

10.38

5.58

1.0

1.1

—

mmol/l

—

Erysipelas

3.57

5.55

1.2

1.1

—

mmol/l

—

Schizophrenia

5.24

5.52

1.2

—

mmol/l

—

Injury, poisoning and certain other consequences of external causes

5.40

5.49

1.2

1.0

—

mmol/l

—

Septicaemia

4.47

5.41

1.1

—

mmol/l

—

Mixed and other personality disorders

16.04

5.41

1.4

1.2

—

mmol/l

—

Insulin, fast-acting or short human

3.72

5.35

1.1

—

mmol/l

—

Episodal and paroxysmal disorders

2.56

5.34

1.1

—

mmol/l

—

Toxic effect of other and unspecified substances

+∞

5.21

1.4

0.0

—

mmol/l

—

Fever of other and unknown origin

3.50

5.13

1.2

1.0

—

mmol/l

—

Chronic viral hepatitis

13.38

5.08

1.1

1.0

—

mmol/l

—

Maltreatment syndromes

13.38

5.08

1.1

1.0

—

mmol/l

—

Nonorganic sleeping disorders, excluding more controls

13.34

5.07

1.1

1.0

—

mmol/l

—

Gout, idiopatic and unspecified

5.27

5.03

1.1

1.2

—

mmol/l

—

Gout, FINNGEN

4.79

5.01

1.3

1.1

—

mmol/l

—

Any reimbursement code in KELA

3.66

4.98

1.2

1.0

—

mmol/l

—

Other nutritional deficiencies

2.93

4.87

1.1

—

mmol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

4.29

4.82

1.0

1.3

—

mmol/l

—

Disorders of gallbladder, biliary tract and pancreas

2.62

4.78

1.1

—

mmol/l

—

Other viral hepatitis

11.46

4.78

1.1

—

mmol/l

—

Sleep disorders

5.00

4.77

1.1

1.3

—

mmol/l

—

Fracture at wrist and hand level

3.57

4.75

1.1

—

mmol/l

—

Heart failure and bmi 25plus

4.27

4.62

1.0

1.3

—

mmol/l

—

Heart failure,strict

3.41

4.61

1.0

1.2

—

mmol/l

—

Decubitus ulcer and pressure area

14.04

4.57

1.0

—

mmol/l

—

Disorders of mineral metabolism

14.03

4.57

1.1

1.0

—

mmol/l

—

Cellulitis

4.77

4.53

1.2

—

mmol/l

—

Transport accidents

4.93

4.52

1.1

1.0

—

mmol/l

—

Viral hepatitis

10.02

4.52

1.1

—

mmol/l

—

Open wound of forearm

10.02

4.52

1.0

—

mmol/l

—

Duodenal ulcer

10.01

4.51

1.4

1.0

—

mmol/l

—

Exposure to other specified factors

2.62

4.51

1.0

1.1

—

mmol/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

3.57

4.43

1.1

1.2

—

mmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

3.29

4.30

1.1

1.2

—

mmol/l

—

Unspecified fall

3.07

4.29

1.1

—

mmol/l

—

Sequelae of injuries of upper limb

11.68

4.27

1.0

—

mmol/l

—

Pain in throat and chest

2.56

4.24

1.2

1.1

—

mmol/l

—

Hyperlipidaemia, other/unspecified

4.17

4.20

1.1

1.2

—

mmol/l

—

Gout

4.18

4.17

1.3

1.1

—

mmol/l

—

Injuries to the elbow and forearm

2.62

4.12

1.0

1.1

—

mmol/l

—

Cerebrovascular diseases (FINNGEN)

4.09

4.12

1.1

1.2

—

mmol/l

—

Fracture of rib(s), sternum and thoracic spine

3.75

4.08

1.2

—

mmol/l

—

Obesity due to excess calories

3.08

4.07

1.1

1.2

—

mmol/l

—

Diseases of the skin and subcutaneous tissue

2.39

4.03

1.1

—

mmol/l

—

Cardiovascular diseases

2.86

4.02

1.2

1.1

—

mmol/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.39

4.01

1.1

—

mmol/l

—

Secondary hypertension

9.92

3.98

1.0

1.4

—

mmol/l

—

Persons with potential health hazards related to communicable diseases

3.31

3.98

1.4

1.1

—

mmol/l

—

Excluding asthma or asthma-COPD overlap

2.95

3.91

1.2

1.1

—

mmol/l

—

Other pulmonary diagnosis

2.95

3.91

1.2

1.1

—

mmol/l

—

COPD differential diagnosis

2.95

3.91

1.2

1.1

—

mmol/l

—

ILD differential diagnosis

2.95

3.91

1.2

1.1

—

mmol/l

—

Syncope and collapse

3.49

3.89

1.2

1.0

—

mmol/l

—

Other fall from one level to another

4.17

3.88

1.0

1.3

—

mmol/l

—

Medical abortion

3.35

3.88

1.1

—

mmol/l

—

All-cause Heart Failure

2.99

3.81

1.0

1.2

—

mmol/l

—

Gout, unspecified

6.01

3.81

1.1

1.0

—

mmol/l

—

Diagnoses used for exclusion with ILD

3.80

1.3

1.2

—

mmol/l

—

Hypertensive diseases (excluding secondary)

2.99

3.79

1.2

—

mmol/l

—

Type 2 diabetes, definitions combined

2.51

3.77

1.1

—

mmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

8.76

3.77

1.0

—

mmol/l

—

Disorders of psychological development

5.96

3.75

1.0

—

Other diseases of urinary system

2.37

3.73

1.2

1.1

—

mmol/l

—

Cardiac arrhythmias

3.11

3.73

1.1

—

mmol/l

—

Hard cardiovascular diseases

2.57

3.68

1.2

1.1

—

mmol/l

—

Superficial injury of abdomen, lower back and pelvis

6.67

3.67

1.1

1.2

—

mmol/l

—

Heart failure, strict

2.91

3.67

1.0

1.2

—

mmol/l

—

Type 2 diabetes, strict (exclude DM1)

2.47

3.66

1.1

—

mmol/l

—

Other diseases of liver

5.63

3.65

1.0

1.3

—

mmol/l

—

Disorders of lipoprotein metabolism and other lipidaemias

2.78

3.64

1.1

—

mmol/l

—

Exclusions for E4_PCOS_CONSORTIUM

2.77

3.62

1.2

1.1

—

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.44

3.62

1.3

1.1

—

mmol/l

—

Hypertension

2.50

3.55

1.2

1.1

—

mmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

2.27

3.55

1.2

1.1

—

mmol/l

—

Sub-endpoint used in defining T1D endpoints

3.37

3.51

1.2

1.1

—

mmol/l

—

Gout, strict definition

6.16

3.50

1.1

1.2

—

mmol/l

—

Hypertensive diseases

2.46

3.43

1.2

1.1

—

mmol/l

—

Asthma

2.84

3.42

1.0

1.1

—

mmol/l

—

Iron deficiency anaemia

3.51

3.42

1.2

—

mmol/l

—

Cystitis

2.60

3.40

1.2

1.1

—

mmol/l

—

Symptoms and signs involving the digestive system and abdomen

2.29

3.38

1.2

1.1

—

mmol/l

—

Acute tubulo-interstitial nephritis

2.89

3.38

1.1

1.2

—

mmol/l

—

Asthma, excluding more controls

2.92

3.38

1.0

1.2

—

mmol/l

—

Other (not insulin) diabetes medications

2.32

3.38

1.1

—

mmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.56

3.37

1.1

1.0

—

mmol/l

—

Abnormal involuntary movements

7.01

3.36

1.3

1.0

—

Headache

2.79

3.34

1.1

1.0

—

mmol/l

—

Hypertension, essential

2.46

3.31

1.2

1.1

—

mmol/l

—

Bronchitis

2.16

3.30

1.1

—

mmol/l

—

Abnormalities of heart beat

3.67

3.30

1.1

—

mmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

2.57

3.27

1.2

—

mmol/l

—

Schizoaffective disorder

8.58

3.26

1.0

1.1

—

mmol/l

—

Tramadol

2.40

3.25

1.1

—

mmol/l

—

Intestinal infectious diseases

2.18

3.25

1.2

1.1

—

mmol/l

—

Biguanides

2.27

3.24

1.1

—

mmol/l

—

Injuries to the hip and thigh

2.91

3.22

1.2

1.1

—

mmol/l

—

Atrial fibrillation and flutter with reimbursement

5.25

3.22

1.0

1.3

—

mmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

2.35

3.19

1.1

—

mmol/l

—

Insomnia

5.34

3.19

1.1

1.2

—

mmol/l

—

Implicit viral Sepsis

6.37

3.18

1.1

1.0

—

mmol/l

—

Viral Sepsis

6.37

3.18

1.1

1.0

—

mmol/l

—

Fracture of lower leg, including ankle

2.57

3.18

1.2

1.1

—

mmol/l

—

Codeine or tramadol medication

2.07

3.17

1.1

—

mmol/l

—

Other soft tissue disorders, not elsewhere classified

2.20

3.17

1.2

1.1

—

mmol/l

—

Sleep disorders (combined)

2.18

3.16

1.1

—

mmol/l

—

Genitourinary diseases

2.65

3.15

1.1

—

mmol/l

—

Codeine

2.20

3.07

1.2

1.1

—

mmol/l

—

Bacterial pneumoniae

3.13

3.07

1.0

1.2

—

mmol/l

—

Assault by bodily force

7.51

3.05

1.0

1.1

—

mmol/l

—

Hypoglycaemia, other or unspecified

7.51

3.05

1.0

—

Phobic anxiety disorders

7.50

3.05

1.0

1.1

—

mmol/l

—

Abdominal and pelvic pain

2.22

3.05

1.2

1.1

—

mmol/l

—

Undetermined asthma

7.50

3.05

1.0

1.3

—

mmol/l

—

Undetermined asthma, excluding more controls

7.50

3.05

1.0

1.3

—

mmol/l

—

Retention of urine

3.32

3.04

1.2

1.3

—

mmol/l

—

Dialysis, with operation codes

5.84

3.02

1.0

1.3

—

mmol/l

—

Acute and transient psychotic disorders

5.84

3.02

1.1

1.3

—

mmol/l

—

Spondyloarthritis

4.29

2.99

1.2

—

mmol/l

—

Injuries to the ankle and foot

2.31

2.96

1.1

—

mmol/l

—

Other respiratory disorders and diseases

4.71

2.91

1.1

—

mmol/l

—

Other diseases of the respiratory system

4.71

2.91

1.1

—

mmol/l

—

Open wound of wrist and hand

2.61

2.90

1.0

1.1

—

mmol/l

—

Obesity

2.44

2.89

1.1

—

mmol/l

—

Obesity and other hyperalimentation

2.44

2.88

1.1

—

mmol/l

—

Symptoms and signs involving the urinary system

2.31

2.88

1.1

—

mmol/l

—

Nephropathy related operations

6.67

2.86

1.0

1.2

—

mmol/l

—

Chronic kidney disease

4.07

2.86

1.0

1.2

—

mmol/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.10

2.84

1.1

—

Care involving use of rehabilitation procedures

2.49

2.81

1.1

—

mmol/l

—

Nonorganic sleeping disorders

4.45

2.79

1.1

1.2

—

mmol/l

—

Injury of other and unspecified intrathoracic organs

8.35

2.75

1.2

1.0

—

mmol/l

—

Smoking dependency

8.34

2.75

1.0

—

Asthma (only as main-diagnosis)

2.66

2.69

1.0

1.1

—

mmol/l

—

Asthma (mode)

2.58

2.65

1.0

1.1

—

mmol/l

—

Gastroduodenal ulcer

3.59

2.56

1.3

1.0

—

mmol/l

—

Non-ischemic cardiomyopathy

3.69

2.56

1.0

1.1

—

mmol/l

—

Asthma (only as main-diagnosis), excluding more controls

2.69

2.55

1.0

1.2

—

mmol/l

—

Eating disorder

7.14

2.54

1.4

1.1

—

Type 1 diabetes, strict (exclude DM2)

5.45

2.54

1.0

1.1

—

mmol/l

—

Type 1 diabetes, definitions combined

5.45

2.53

1.0

1.1

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.98

2.53

1.1

—

mmol/l

—

Other heart diseases, wide

2.01

2.51

1.1

—

mmol/l

—

Bacterial pneumonia (organism specified)

2.73

2.50

1.0

1.2

—

mmol/l

—

Other and unspecified iron deficiency

3.46

2.47

1.0

1.2

—

mmol/l

—

Dysphagia

4.38

2.47

1.1

1.2

—

mmol/l

—

Early onset COPD, excluding more controls

4.37

2.47

1.0

1.3

—

mmol/l

—

Diseases of the respiratory system

2.70

2.44

1.1

—

mmol/l

—

Injuries to the knee and lower leg

1.89

2.40

1.1

—

mmol/l

—

Suppurative and unspecified otitis media

2.66

2.37

1.1

1.2

—

mmol/l

—

Eating disorders

6.25

2.37

1.4

1.1

—

Paralytic ileus and intestinal obstruction

3.64

2.36

1.0

1.1

—

mmol/l

—

Other noninfective gastroenteritis and colitis

3.63

2.36

1.0

1.2

—

mmol/l

—

Opioids

1.99

2.35

1.2

1.1

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases

1.92

2.35

1.1

—

mmol/l

—

Other arthrosis

2.38

2.31

1.0

1.1

—

mmol/l

—

Abnormalities of breathing

2.04

2.29

1.0

1.1

—

mmol/l

—

Factors influencing health status and contact with health services

4.01

2.28

1.0

—

mmol/l

—

Haemorrhage from respiratory passages

3.21

2.28

1.1

—

mmol/l

—

Superficial injury of thorax

4.62

2.27

1.2

—

mmol/l

—

Superficial injury of forearm

5.56

2.21

1.0

1.1

—

Abnormalities of gait and mobility

5.56

2.21

1.0

1.2

—

Panic disorder

5.56

2.21

1.0

1.1

—

Intracerebral haemorrhage

5.56

2.21

1.0

1.2

—

mmol/l

—

Hernia of abdominal wall

2.41

2.19

1.3

1.1

—

mmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

2.15

2.18

1.2

1.0

—

mmol/l

—

Constipation

2.01

2.18

1.1

—

mmol/l

—

Other condition

4.29

2.15

1.0

1.3

—

mmol/l

—

Migraine without aura

4.29

2.15

1.0

1.2

—

Spondylopathies (FG)

3.69

2.15

1.3

—

mmol/l

—

Gastro-oesophageal reflux disease

2.12

1.2

1.1

—

mmol/l

—

Acute bronchitis

2.72

2.11

1.1

1.2

—

mmol/l

—

Autoimmune diseases

1.83

2.11

1.1

—

mmol/l

—

Any gastric operation

2.12

2.08

1.2

1.0

—

mmol/l

—

GASTRO-related operations

2.12

2.08

1.2

1.0

—

mmol/l

—

Pain (limb, back, neck, head abdominally)

2.12

2.08

1.3

1.1

—

mmol/l

—

Nonalcoholic fatty liver disease

5.01

2.07

1.0

1.2

—

mmol/l

—

Type 1 diabetes, wide definition, subgroup 1

3.50

2.05

1.0

1.1

—

mmol/l

—

Direct fill therapy

4.00

2.03

1.2

1.1

—

Pain in limb

2.02

2.03

1.1

—

mmol/l

—

Dental pulpitis 3, only avohilmo

5.22

2.02

1.0

—

Diseases of pulp and periapical tissues

2.50

2.01

1.3

1.1

—

mmol/l

—

Speech and linguistic disorders

4.80

2.00

1.0

—

Bacterial pneumonia, not elsewhere classified

2.84

1.99

1.0

1.2

—

mmol/l

—

Contact with and exposure to communicable diseases

2.62

1.99

1.6

1.1

—

mmol/l

—

Atrial fibrillation and flutter

2.94

1.98

1.0

1.2

—

mmol/l

—

Soft tissue disorders

1.83

1.96

1.1

—

mmol/l

—

Bitten or struck by other mammals

4.55

1.94

1.0

1.2

—

mmol/l

—

Generalized anxiety disorder

4.55

1.94

1.2

1.1

—

Diseases of middle ear and mastoid

2.16

1.93

1.1

1.2

—

mmol/l

—

Superficial injury of head

3.75

1.93

1.2

—

mmol/l

—

Fall on same level involving ice and snow

2.11

1.91

1.2

1.1

—

mmol/l

—

Dentinal caries

2.71

1.91

1.1

—

Dental caries

2.70

1.90

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.87

1.90

1.1

—

mmol/l

—

Oedema, not elsewhere classified

3.17

1.86

1.0

—

mmol/l

—

Covid-19 confirmed case

2.86

1.86

1.1

1.3

—

mmol/l

—

Superficial injury of lower leg

3.04

1.79

1.0

1.3

—

mmol/l

—

Type 1 diabetes, wide definition

3.04

1.79

1.0

1.1

—

mmol/l

—

Other problems related to primary support group, including family circumstances

4.06

1.78

1.0

1.2

—

Congenital malformations of the circulatory system

4.04

1.77

1.0

1.1

—

mmol/l

—

Other heart diseases

2.33

1.76

1.0

1.2

—

mmol/l

—

Dental caries 3, only avohilmo

2.00

1.76

1.4

1.0

—

mmol/l

—

Other viral diseases, not elsewhere classified

3.33

1.74

1.2

—

mmol/l

—

Presence of other functional implants

2.30

1.74

1.2

—

mmol/l

—

Intestinal stricture

2.67

1.72

1.0

1.2

—

mmol/l

—

Fracture of foot, except ankle

2.92

1.72

1.1

1.2

—

mmol/l

—

All influenza

2.92

1.72

1.1

1.2

—

mmol/l

—

Parodontitis, under 40 years and operation codes

3.85

1.71

1.0

1.1

—

mmol/l

—

Parodontitis, operation under 40 years and operation codes

3.85

1.71

1.0

1.1

—

mmol/l

—

Parodontitis, under 40 years

3.85

1.71

1.0

1.1

—

mmol/l

—

Parodontitis, under 40 years, or operation codes

3.85

1.71

1.0

1.1

—

mmol/l

—

Diplopia

3.85

1.71

1.0

1.3

—

mmol/l

—

Insulin, fast-acting (human)

3.85

1.71

1.0

1.1

—

mmol/l

—

Abnormal serum enzyme levels

2.47

1.70

1.0

1.2

—

mmol/l

—

Dentofacial anomalies [including malocclusion]

2.64

1.70

1.0

1.1

—

mmol/l

—

Used for control exclusion in common control thyroid runs

1.73

1.69

1.1

—

mmol/l

—

Gastrointestinal diseases

2.19

1.69

1.2

1.0

—

mmol/l

—

Dental pulpitis 3

4.00

1.68

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.90

1.68

1.1

—

mmol/l

—

Osteoporosis

3.18

1.66

1.0

1.1

—

mmol/l

—

Ganglion

3.16

1.66

1.0

1.3

—

Hernia

1.78

1.65

1.2

1.1

—

mmol/l

—

Other acute lower respiratory infections

2.10

1.65

1.1

—

mmol/l

—

Irritable bowel syndrome

2.80

1.65

1.1

—

mmol/l

—

Acetic acid derivatives and related substances

2.78

1.64

1.1

1.0

—

mmol/l

—

Migraine with aura

3.57

1.61

1.2

—

Focal epilepsy

3.00

1.58

1.0

1.4

—

mmol/l

—

Sequelae of external causes of morbidity and mortality

2.69

1.58

1.3

—

mmol/l

—

Codes for special purposes

2.20

1.56

1.1

1.2

—

mmol/l

—

Provisional assignment of new diseases of uncertain etiology

2.20

1.56

1.1

1.2

—

mmol/l

—

Spondylopathies

1.83

1.54

1.1

—

mmol/l

—

Asthma-related pneumonia

2.42

1.53

1.0

1.2

—

mmol/l

—

Asthma, hospital admissions 3, pneumonia

2.42

1.53

1.0

1.2

—

mmol/l

—

Asthma-related pneumonia or sepsis

2.42

1.53

1.0

1.2

—

mmol/l

—

Diseases of oesophagus, stomach and duodenum

1.70

1.53

1.3

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.27

1.52

1.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.33

1.52

1.0

1.3

—

Other or unspecified ileus, impaction or obstruction

3.33

1.52

1.0

1.1

—

mmol/l

—

Low back pain

1.82

1.52

1.1

—

mmol/l

—

Early onset COPD

2.59

1.51

1.0

1.3

—

mmol/l

—

Injuries to the neck

2.59

1.51

1.0

1.3

—

mmol/l

—

Acute and subacute iridocyclitis

2.86

1.50

1.2

1.3

—

mmol/l

—

Anterior Iridocyclitis

2.86

1.50

1.2

1.3

—

mmol/l

—

Major coronary heart disease event excluding revascularizations

1.95

1.50

1.2

1.1

—

mmol/l

—

Abnormal findings on examination of blood, without diagnosis

2.08

1.49

1.0

1.2

—

mmol/l

—

Acute suppurative otitis media

2.47

1.49

1.1

—

mmol/l

—

Polyarthropathies

1.90

1.49

1.2

1.1

—

mmol/l

—

Finngen Rheumatological endpoints

1.70

1.47

1.2

1.1

—

mmol/l

—

Statin medication

1.87

1.45

1.2

1.1

—

mmol/l

—

Dental caries 3 and operation codes

1.81

1.43

1.3

1.0

—

mmol/l

—

Nasal polyp

2.73

1.43

1.0

1.3

—

mmol/l

—

Stroke, excluding SAH

2.01

1.43

1.1

1.2

—

mmol/l

—

Other diseases of pleura

2.22

1.42

1.1

1.2

—

mmol/l

—

COPD related to multimorbidity

2.30

1.41

1.0

1.2

—

mmol/l

—

Other headache syndromes

2.25

1.40

1.0

1.2

—

Unspecified haematuria

2.20

1.39

1.0

1.2

—

mmol/l

—

Oxicams

2.84

1.38

1.2

1.0

—

mmol/l

—

Dental pulpitis 2

1.99

1.38

1.4

1.0

—

mmol/l

—

Polyarthrosis

3.00

1.37

1.0

1.1

—

mmol/l

—

Iridocyclitis

2.61

1.36

1.2

1.3

—

mmol/l

—

Superficial injury of wrist and hand

2.94

1.36

1.4

1.2

—

mmol/l

—

Focal epilepsy, strict definition

2.94

1.36

1.0

1.3

—

mmol/l

—

Other diseases of intestines

1.61

1.35

1.2

1.1

—

mmol/l

—

COPD (mode)

2.65

1.35

1.0

1.3

—

mmol/l

—

Dental caries 1, only avohilmo

1.86

1.33

1.4

1.0

—

mmol/l

—

Migraine

2.13

1.31

1.1

1.2

—

Dental caries 1 and operation codes

1.78

1.31

1.3

1.0

—

mmol/l

—

Myocardial infarction

2.00

1.31

1.2

1.1

—

mmol/l

—

Dermatitis and eczema

1.61

1.31

1.1

—

mmol/l

—

AV-block

2.84

1.30

1.0

1.1

—

mmol/l

—

Oxycodone

2.34

1.28

1.0

1.2

—

mmol/l

—

Fracture of skull and facial bones

2.78

1.28

1.0

1.2

—

mmol/l

—

Pain, not elsewhere classified

2.78

1.28

1.2

1.0

—

mmol/l

—

Nontraumatic intracranial haemmorrhage

2.78

1.28

1.0

1.1

—

mmol/l

—

Fracture of lumbar spine and pelvis

2.77

1.28

1.0

1.2

—

mmol/l

—

Unstable angina pectoris

2.29

1.26

1.1

—

mmol/l

—

Benign lipomatous neoplasm

2.40

1.24

1.2

—

mmol/l

—

Obesity related asthma

2.22

1.24

1.0

1.2

—

mmol/l

—

Stroke, including SAH

1.89

1.22

1.1

1.2

—

mmol/l

—

Other abnormal products of conception

2.78

1.22

1.0

1.3

—

mmol/l

—

Dyspnoea

1.68

1.20

1.1

—

mmol/l

—

Pacemaker

2.33

1.20

1.0

1.1

—

mmol/l

—

Mycoses

2.31

1.18

1.2

—

mmol/l

—

Fracture of shoulder and upper arm

2.10

1.18

1.5

1.0

—

mmol/l

—

Myocardial infarction, without ST-elevation

2.11

1.18

1.0

1.2

—

Myocardial infarction, strict

1.96

1.15

1.0

1.1

—

mmol/l

—

Complications of surgical and medical care, not elsewhere classified

1.61

1.14

1.1

—

mmol/l

—

Injuries to the shoulder and upper arm

1.64

1.13

1.3

1.1

—

mmol/l

—

Dental caries 3

1.74

1.11

1.4

1.0

—

mmol/l

—

Coxibs

2.33

1.11

1.1

1.0

—

Other arthritis (FG)

2.26

1.10

1.1

1.2

—

mmol/l

—

Asthma-related infections

1.78

1.09

1.0

1.1

—

mmol/l

—

Asthma, hospital admission 2, infections

1.78

1.09

1.0

1.1

—

mmol/l

—

COPD, hospital admission 2, with asthma infections

2.21

1.08

1.0

1.2

—

mmol/l

—

Diseases of the eye and adnexa

1.59

1.08

1.2

1.1

—

mmol/l

—

Glaucoma suspect

2.19

1.08

1.3

1.1

—

mmol/l

—

Other/unspecified dorsalgia

1.94

1.08

1.0

1.1

—

mmol/l

—

Postmenopausal bleeding

2.50

1.06

1.0

1.1

—

mmol/l

—

Myocardial infarction, unclassifiable

2.35

1.06

1.4

1.1

—

mmol/l

—

Dental caries 3 and operation codes, only avohilmo

2.20

1.05

1.1

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.13

1.05

1.0

1.1

—

mmol/l

—

COPD, hospital admissions

2.00

1.05

1.0

1.2

—

mmol/l

—

COPD, early/later onset

2.00

1.05

1.0

1.2

—

mmol/l

—

Other functional intestinal disorders

1.99

1.04

1.2

1.0

—

mmol/l

—

Pure hypercholesterolaemia

1.89

1.04

1.1

—

mmol/l

—

Labour and delivery complicated by fetal stress [distress]

2.38

1.04

1.4

1.2

—

mmol/l

—

Disorders of other endocrine glands

1.97

1.03

1.0

1.2

—

mmol/l

—

Polyuria

2.27

1.03

1.4

1.3

—

mmol/l

—

Viral infections characterized by skin and mucous membrane lesions

1.96

1.03

1.0

1.2

—

mmol/l

—

Urticaria and erythema

2.06

1.02

1.1

1.2

—

mmol/l

—

Atopic dermatitis, strict definition with reimbursement

2.06

1.02

1.3

1.2

—

mmol/l

—

Other viral diseases

2.05

1.02

1.1

—

mmol/l

—

Other diseases of upper respiratory tract

1.50

1.02

1.0

1.1

—

mmol/l

—

Disorders of synovium and tendon

1.83

1.01

1.0

1.1

—

mmol/l

—

Cerebrovascular diseases

1.68

1.01

1.1

—

mmol/l

—

Extrapyramidal and movement disorders

2.00

1.00

1.3

1.2

—

mmol/l

—

Other chronic obstructive pulmonary disease

1.87

1.00

1.0

1.2

—

mmol/l

—

Dental caries, including avohilmo

1.70

0.99

1.5

1.0

—

mmol/l

—

Dental caries 1

1.70

0.99

1.5

1.0

—

mmol/l

—

Dizziness and giddiness

1.73

0.99

1.1

1.0

—

mmol/l

—

Glomerular diseases

2.17

0.98

1.2

—

mmol/l

—

Functional dyspepsia

2.17

0.98

1.4

1.1

—

mmol/l

—

Sleep apnoea, including avohilmo

1.54

0.98

1.1

—

mmol/l

—

Major coronary heart disease event

1.70

0.97

1.2

1.1

—

mmol/l

—

Other neurological diseases

1.68

0.97

1.0

1.1

—

mmol/l

—

Sleep apnoea

1.55

0.96

1.1

—

mmol/l

—

Cough

1.92

0.95

1.0

1.1

—

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

1.79

0.94

1.0

1.2

—

mmol/l

—

Dental pulpitis 2, only avohilmo

1.75

0.94

1.4

1.0

—

mmol/l

—

Benign lipomatous neoplasm

2.22

0.93

1.2

—

mmol/l

—

Glaucoma

1.83

0.91

1.3

1.1

—

mmol/l

—

Autoimmune diseases related-to ILD

1.56

0.91

1.1

—

mmol/l

—

Disorders of lens

1.67

0.91

1.3

1.1

—

mmol/l

—

Parodontitis

1.54

0.90

1.2

1.1

—

mmol/l

—

Parodontitis or operation codes

1.54

0.90

1.2

1.1

—

mmol/l

—

1.80

0.90

1.0

1.2

—

mmol/l

—

Noninfective enteritis and colitis

1.74

0.89

1.0

1.2

—

mmol/l

—

Dental operations

1.71

0.88

1.3

1.1

—

mmol/l

—

Heart failure and coronary heart disease

2.03

0.87

1.0

1.1

—

mmol/l

—

Psoriasis

1.94

0.84

1.0

1.2

—

mmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

1.94

0.84

1.0

1.2

—

mmol/l

—

Other medical care

1.89

0.82

1.0

1.2

—

mmol/l

—

Asthma (diagnoses ohter than nonallergic)

1.51

0.82

1.0

1.1

—

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

1.62

0.82

1.0

1.1

—

mmol/l

—

Osteopathies and chondropathies

1.68

0.80

1.0

1.1

—

mmol/l

—

Dorsalgia

1.46

0.80

1.0

1.1

—

mmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.79

0.0

1.2

—

Chronic gastritis

0.00

0.79

0.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.79

0.0

1.2

—

Seropositive rheumatoid arthritis, wide

0.00

0.79

0.0

1.2

—

Rotator cuff syndrome

1.65

0.79

1.1

—

mmol/l

—

Effects of foreign body entering through natural orifice

1.82

0.79

1.0

1.2

—

mmol/l

—

Diseases of external ear

1.82

0.79

1.0

1.2

—

Obesity, other/unspecified

1.82

0.79

1.0

1.2

—

mmol/l

—

Tinnitus

0.00

0.79

0.0

1.3

—

Special screening examination for infectious and parasitic diseases

0.00

0.78

0.0

1.1

—

Conduction disorders

1.78

0.76

1.0

1.3

—

mmol/l

—

COPD

1.73

0.76

1.0

1.2

—

mmol/l

—

Impingement syndrome of shoulder

0.00

0.76

0.0

1.2

—

Other diseases of blood and blood-forming organs, wide

2.08

0.74

1.0

1.2

—

mmol/l

—

Ventral hernia

2.00

0.72

1.8

1.2

—

mmol/l

—

Umbilical hernia

1.75

0.71

1.0

1.2

—

mmol/l

—

Other diseases of anus and rectum

1.92

0.70

1.4

1.1

—

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

1.57

0.70

1.0

1.1

—

mmol/l

—

Lower back pain or/and sciatica

1.42

0.70

1.1

—

mmol/l

—

Gonarthrosis, primary, with knee surgery

1.56

0.70

1.0

1.2

—

mmol/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1.71

0.69

1.0

1.2

—

mmol/l

—

Chronic periapical parodontitis

1.85

0.68

1.4

1.1

—

Fracture of forearm

1.64

0.68

1.0

1.1

—

mmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.85

0.68

1.0

1.1

—

mmol/l

—

Coronary atherosclerosis

1.58

0.67

1.0

1.1

—

mmol/l

—

Ischaemic Stroke, excluding all haemorrhages

1.64

0.66

1.1

1.2

—

mmol/l

—

Other specified/unspecified arthritis

1.79

0.66

1.2

1.1

—

mmol/l

—

Medical observation and evaluation for suspected diseases and conditions

1.53

0.66

1.1

1.0

—

mmol/l

—

Asthma, including avohilmo

1.36

0.65

1.1

—

mmol/l

—

Dental caries 1 and operation codes, only avohilmo

1.80

0.64

1.0

—

Chronic lower respiratory diseases

1.35

0.64

1.0

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.72

0.64

1.0

1.2

—

mmol/l

—

Sulfonylureas

1.73

0.63

1.0

1.2

—

mmol/l

—

1.39

0.62

1.1

—

mmol/l

—

Disorders of choroid and retina

1.48

0.62

1.0

1.1

—

mmol/l

—

Ischaemic heart disease, wide definition

1.48

0.62

1.2

1.1

—

mmol/l

—

Complications of medical and surgical care

1.49

0.61

1.1

—

mmol/l

—

Maternal care for other known or suspected fetal problems

0.00

0.61

0.0

1.1

—

Transient ischemic attack

1.58

0.60

1.0

1.2

—

mmol/l

—

Corneal ulcer

0.00

0.60

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.60

0.0

1.1

—

Seborrhoeic keratosis

0.00

0.60

0.0

1.2

—

Dental caries 2 and operation codes, only avohilmo

0.60

1.0

1.1

—

mmol/l

—

False labour

1.79

0.59

1.5

1.1

—

Visual disturbances and blindness

1.54

0.59

1.0

1.1

—

mmol/l

—

Seropositive rheumatoid arthritis

0.00

0.59

0.0

1.1

—

Parodontitis and operation codes

1.41

0.58

1.2

1.1

—

mmol/l

—

Certain disorders involving the immune mechanism

0.00

0.58

0.0

1.3

—

Voice disturbances

0.00

0.58

0.0

1.2

—

Ischemic heart diseases

1.46

0.58

1.2

1.1

—

mmol/l

—

Parodontitis or/and operation codes

1.46

0.57

1.2

1.1

—

mmol/l

—

Diaphragmatic hernia

1.67

0.56

1.3

1.1

—

mmol/l

—

Gonarthrosis,primary

1.43

0.56

1.0

1.1

—

mmol/l

—

Hypothyroidism, strict autoimmune

1.46

0.54

1.1

—

mmol/l

—

Shoulder lesions

1.43

0.53

1.1

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.53

0.49

1.4

1.2

—

mmol/l

—

Cholelithiasis, broad definition with cholecystitis

1.41

0.48

1.1

—

mmol/l

—

Other cataract

1.51

0.48

1.1

—

mmol/l

—

Angina pectoris

1.50

0.48

1.1

—

mmol/l

—

Visual disturbances

1.46

0.46

1.0

1.1

—

mmol/l

—

Chronic periodontitis, including avohilmo

1.35

0.46

1.2

1.1

—

mmol/l

—

Other disorders of skin and subcutaneous tissue

1.44

0.46

1.0

1.2

—

mmol/l

—

Cholecystectomy

1.43

0.45

1.1

—

mmol/l

—

Benign neoplasms

1.30

0.45

1.2

1.1

—

mmol/l

—

Dental operations, only avohilmo

1.43

0.45

1.4

1.0

—

mmol/l

—

Asthma, hospital admissions , main diagnosis only

100

1.34

0.44

1.0

1.1

—

mmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.40

0.44

1.3

1.0

—

mmol/l

—

malignant neoplasm of male genital organs

1.45

0.43

1.0

1.2

—

mmol/l

—

Cholelithiasis

1.40

0.43

1.1

—

mmol/l

—

Benign neoplasm: Colon

1.46

0.43

1.3

1.1

—

mmol/l

—

ILD medications

1.27

0.43

1.2

1.1

—

mmol/l

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.28

0.42

1.2

1.1

—

mmol/l

—

Appendectomy

0.66

0.42

1.2

1.1

—

mmol/l

—

Postmenopausal atrophic vaginitis

0.00

0.42

0.0

1.1

—

Benign neoplasm: Colon

1.40

0.42

1.3

1.1

—

mmol/l

—

Examination and observation for other reasons

1.42

0.42

1.2

1.0

—

mmol/l

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.1

—

Use of memantine

0.00

0.41

0.0

1.1

—

Use of other anti-dementia drugs

0.00

0.41

0.0

1.1

—

Prolonged pregnancy

0.00

0.41

0.0

1.1

—

Thyroiditis, ILD-related definition

0.00

0.41

0.0

1.2

—

Other inflammation of eyelid

0.00

0.41

0.0

1.2

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.41

0.0

1.2

—

Benign neoplasm: Sigmoid colon

0.00

0.41

0.0

1.3

—

Lichen planus, including avohilmo

0.00

0.41

0.0

1.2

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.3

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.2

—

Benign neoplasm: Sigmoid colon

0.00

0.41

0.0

1.1

—

Presence of other devices

0.00

0.41

0.0

1.1

—

Arthrosis

1.37

0.41

1.0

1.1

—

mmol/l

—

Endometriosis

1.49

0.41

1.2

1.1

—

mmol/l

—

Chondropathies

0.00

0.40

0.0

1.2

—

Complications of procedures, not elsewhere classified

1.35

0.40

1.0

1.1

—

mmol/l

—

Propionic acid derivatives

1.48

0.40

1.0

—

mmol/l

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.40

0.0

1.1

—

Sulfasalazine

1.47

0.40

1.4

1.2

—

mmol/l

—

Retinal detachments and breaks

1.47

0.40

1.0

1.3

—

mmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.40

0.0

1.2

—

Spondylosis

1.32

0.40

1.0

1.1

—

mmol/l

—

Atopic dermatitis, strict definition

1.44

0.39

1.4

1.1

—

mmol/l

—

Diseases of the musculoskeletal system and connective tissue

1.42

0.39

1.2

1.1

—

mmol/l

—

Other skin changes

0.00

0.39

0.0

1.2

—

Tonsillectomy and adenotomy

1.39

0.39

1.1

—

mmol/l

—

Diabetic retinopathy, excluding more controls

1.41

0.38

1.0

1.2

—

mmol/l

—

Acute sinusitis

1.38

0.38

1.0

1.1

—

mmol/l

—

Other retinal disorders

1.41

0.38

1.0

1.2

—

mmol/l

—

Diseases of male genital organs

1.34

0.37

1.1

—

mmol/l

—

Dental caries 2

0.71

0.37

1.0

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.35

0.37

1.6

1.0

—

mmol/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.30

0.37

1.0

1.2

—

mmol/l

—

Reimbursement for rheumatic diseases

1.30

0.37

1.3

1.1

—

mmol/l

—

Other diseases of hard tissues of teeth

1.37

0.36

1.2

1.1

—

mmol/l

—

Temporomandibular joint disorders, including avohilmo

1.43

0.35

1.3

1.1

—

mmol/l

—

Acute upper respiratory infections

1.27

0.34

1.1

—

mmol/l

—

Irregular menses

1.35

0.34

1.5

1.1

—

mmol/l

—

Asthma/COPD (KELA code 203)

1.26

0.34

1.1

—

mmol/l

—

Peripheral artery disease

1.34

0.34

1.0

1.2

—

Presence of cardiac and vascular implants and grafts

1.34

0.34

1.0

1.1

—

mmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.36

0.33

1.0

1.2

—

mmol/l

—

Benign neoplasms

1.29

0.33

1.3

1.1

—

mmol/l

—

Papulosquamous disorders

1.30

0.33

1.0

1.2

—

mmol/l

—

Cervical disc disorders

1.28

0.32

1.3

1.1

—

mmol/l

—

Oral corticosteroids

1.24

0.32

1.2

1.1

—

mmol/l

—

Nerve, nerve root and plexus disorders

1.24

0.32

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

1.33

0.32

1.0

1.1

—

mmol/l

—

Malignant neoplasm

1.27

0.31

1.1

—

mmol/l

—

Coronary revascularization (ANGIO or CABG)

1.28

0.30

1.0

1.1

—

mmol/l

—

Dental caries 2, only avohilmo

0.72

0.29

1.0

1.1

—

mmol/l

—

Dental caries 2 and operation codes

0.72

0.29

1.0

1.1

—

mmol/l

—

Diseases of the ear and mastoid process

1.21

0.29

1.0

1.1

—

mmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.32

0.28

1.1

—

mmol/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.25

0.28

1.1

—

mmol/l

—

Malignant neoplasm, wide definition for exclusion

1.25

0.28

1.1

—

mmol/l

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.25

0.28

1.1

—

mmol/l

—

Other arrhythmias

1.32

0.27

1.2

—

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

1.24

0.27

1.3

1.1

—

mmol/l

—

Pain in joint

1.23

0.27

1.0

1.1

—

mmol/l

—

Inguinal hernia

1.26

0.25

1.2

1.1

—

mmol/l

—

1.34

0.23

1.0

1.1

—

mmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.33

0.23

1.0

1.2

—

mmol/l

—

Cardiodefibrillation

1.31

0.23

1.0

1.2

—

mmol/l

—

Disorders of lacrimal system

1.28

0.23

1.0

1.2

—

mmol/l

—

Malignant neoplasm of breast, HER2-negative

1.27

0.23

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.26

0.22

1.0

1.1

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.26

0.22

1.0

1.1

—

Malignant neoplasm of breast

1.24

0.22

1.0

1.1

—

DVT of lower extremities and pulmonary embolism

1.25

0.22

1.0

1.2

—

mmol/l

—

Fenamates

0.00

0.22

0.0

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.21

0.22

1.0

1.2

—

mmol/l

—

Alzheimer’s disease (Late onset)

0.00

0.21

0.0

1.0

—

Conductive and sensorineural hearing loss

0.77

0.21

1.1

—

mmol/l

—

Triptan medication for migraine, single purchase ok

1.22

0.21

1.2

1.1

—

mmol/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.22

0.21

1.2

1.1

—

mmol/l

—

Other Crohn's disease

0.00

0.21

0.0

1.1

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.1

—

Other and unspecified rosacea

0.00

0.21

0.0

1.3

—

Other and/or unspecified nontoxic goitre

0.00

0.21

0.0

1.2

—

Eustachian salpingitis and obstruction

0.00

0.21

0.0

1.1

—

Acne vulgaris

0.00

0.21

0.0

1.1

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.2

—

Inguinal hernia, bilateral

0.00

0.21

0.0

1.0

—

Inguinal or femoral hernia, bilateral

0.00

0.21

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.21

0.0

1.1

—

Pain associated with micturition

0.00

0.21

0.0

1.1

—

Benign neoplasm of breast

0.00

0.21

0.0

1.3

—

Benign neoplasm of breast

0.00

0.21

0.0

1.3

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.2

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.2

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.3

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.2

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.21

0.0

1.0

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.3

—

Arthropathies

1.20

0.21

1.2

1.1

—

mmol/l

—

Conjunctivitis

0.79

0.21

1.0

1.1

—

mmol/l

—

Rosacea

0.00

0.21

0.0

1.3

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Melanocytic naevi of trunk

0.00

0.21

0.0

1.2

—

Melanocytic naevi of trunk

0.00

0.21

0.0

1.2

—

Lichen planus

0.00

0.21

0.0

1.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

1.2

—

Crohn disease

0.00

0.21

0.0

1.2

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

1.2

—

Unspecified lump in breast

0.00

0.21

0.0

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.21

0.0

1.2

—

Senile cataract

1.27

0.21

1.3

1.1

—

mmol/l

—

Graves disease, strict definition

0.00

0.21

0.0

1.2

—

Recurring oral aphthae, including avohilmo

0.00

0.21

0.0

1.2

—

Other metabolic disorders

0.00

0.21

0.0

1.2

—

Malignant melanoma

0.00

0.21

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.2

—

Acne

0.00

0.21

0.0

1.1

—

Perineal laceration during delivery

0.00

0.20

0.0

1.3

—

Other intervertebral disc disorders

0.79

0.20

1.2

1.1

—

mmol/l

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.20

0.0

1.3

—

Sarcoidosis

0.00

0.20

0.0

1.2

—

Allergic contact dermatitis

0.00

0.20

0.0

1.2

—

Radiculopathy

0.00

0.20

0.0

1.4

—

Endometriosis of pelvic peritoneum

0.00

0.20

0.0

1.1

—

Disorders of conjunctiva

0.78

0.20

1.0

1.1

—

mmol/l

—

Pregnancy with abortive outcome

1.16

0.19

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.24

0.18

1.4

1.1

—

mmol/l

—

Excessive attrition of teeth

1.19

0.18

1.3

1.1

—

mmol/l

—

Dorsopathies

1.16

0.18

1.1

—

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.19

0.18

1.3

1.1

—

Venous thromboembolism

1.19

0.18

1.1

—

mmol/l

—

Other joint disorders

1.17

0.17

1.2

1.1

—

mmol/l

—

Coxarthrosis, primary

0.75

0.17

1.0

1.2

—

mmol/l

—

Sciatica+with lumbago

1.11

0.17

1.1

—

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

1.16

0.16

1.3

1.1

—

mmol/l

—

L04AX Other immunosuppressants

1.10

0.15

1.0

1.1

—

mmol/l

—

Other dorsopathies, not elsewhere classified

1.15

0.15

1.2

1.1

—

mmol/l

—

Other specific joint derangements/joint disorders

1.18

0.15

1.0

1.1

—

mmol/l

—

Sensorineural hearing loss

0.82

0.14

1.1

—

mmol/l

—

Gonarthrosis

1.19

0.13

1.0

1.1

—

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

0.82

0.13

1.0

1.1

—

mmol/l

—

Hypothyroidism, other/unspecified

1.14

0.12

1.1

—

mmol/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.14

0.12

1.1

—

mmol/l

—

Persons encountering health services for examination and investigation

1.17

0.12

1.3

1.0

—

mmol/l

—

Diseases of oral cavity, salivary glands and jaws

1.14

0.11

1.2

1.1

—

mmol/l

—

Chronic diseases of tonsils and adenoids

1.14

0.11

1.1

—

mmol/l

—

Inflammatory bowel disease treatment related agents

1.10

0.10

1.2

1.1

—

mmol/l

—

Degeneration of macula and posterior pole

1.15

0.10

1.0

1.1

—

mmol/l

—

Coronary angioplasty

1.10

0.09

1.0

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.14

0.09

1.1

—

mmol/l

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1.08

0.09

1.0

1.2

—

mmol/l

—

Glucosamine medication

1.05

0.09

1.0

1.1

—

mmol/l

—

Neoplasms

1.12

0.09

1.3

1.1

—

mmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.13

0.09

1.0

1.2

—

mmol/l

—

Hyperplasia of prostate

1.07

0.09

1.0

1.1

—

mmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

0.81

0.08

1.0

1.2

—

mmol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.03

0.08

1.0

1.2

—

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

0.80

0.08

1.0

1.1

—

mmol/l

—

Diseases of inner ear

0.79

0.08

1.0

1.1

—

mmol/l

—

Emergency coronary revascularization (for ACS)

1.07

0.08

1.0

1.1

—

mmol/l

—

Polycystic ovarian syndrome, consortium definition

1.03

0.08

1.4

1.0

—

mmol/l

—

Atopic dermatitis

1.03

0.08

1.3

1.1

—

mmol/l

—

Meniscus derangement

0.82

0.08

1.2

1.1

—

mmol/l

—

Disorders of sclera, cornea, iris and ciliary body

1.03

0.07

1.1

—

mmol/l

—

Artrosis, including avohilmo

1.11

0.07

1.2

1.1

—

mmol/l

—

Second line medication for Crohn's disease

1.04

0.07

1.0

1.1

—

mmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

0.86

0.07

1.1

—

mmol/l

—

ILD medications: immunosuppressive drugs

1.04

0.07

1.2

1.1

—

mmol/l

—

Diseases of appendix

0.92

0.03

1.4

1.1

—

mmol/l

—

Appendicitis, broad definition

0.92

0.03

1.4

1.1

—

mmol/l

—

Other disorders of ear

0.93

0.03

1.1

—

mmol/l

—

Artificial joint operation, meniscal resection

1.07

0.02

1.1

—

mmol/l

—

Any event in cancer register

0.95

0.01

1.0

1.1

—

mmol/l

—

Acute appendicitis

0.98

0.00

1.4

1.1

—

mmol/l

—

First line medication for Crohn's disease

1.03

0.00

1.2

1.1

—

mmol/l

—

Disorders of the thyroid gland

0.99

0.00

1.1

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.97

0.00

1.2

1.1

—

mmol/l

—

Gingivitis and periodontal diseases

0.98

0.00

1.2

1.1

—

mmol/l

—

Impacted maxillary molar

0.00

0.0

1.0

—

Amblyopia ex anopsia

0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

0.0

1.3

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Female infertility, associated with anovulation

0.00

0.0

1.1

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Mouth breathing

0.98

0.00

1.0

1.1

—

mmol/l

—

Chronic iridocyclitis

0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

0.0

1.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

0.0

1.2

—

Viral meningitis

0.00

0.0

1.0

—

Other erythematous conditions

0.00

0.0

1.0

—

Complications of labour and delivery

0.90

0.00

1.0

1.1

—

Pedestrian injured in transport accident

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.3

—

Benign neoplasm: Stomach

0.00

0.0

1.0

—

Cardiac murmurs and other cardiac sounds

0.00

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.0

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.0

1.0

—

Ovarian dysfunction

0.00

0.0

1.2

—

Multiple delivery

0.00

0.0

1.1

—

Care involving dialysis

0.00

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.0

—

Separation of retinal layers (serosa)

0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

0.0

1.0

—

Carpal tunnel syndrome

0.93

0.00

1.1

—

mmol/l

—

Immunodeficiencies

0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.0

1.0

—

Other and unspecified coagulation defects

0.00

0.0

1.1

—

Recurrent dislocation of patella

0.00

0.0

1.2

—

Benign neoplasm: Caecum

0.00

0.0

1.0

—

Asthma and allergy, excluding more controls

0.00

0.0

1.4

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.1

—

Osteomyelitis

0.00

0.0

1.0

—

Malignant neoplasm of prostate

0.93

0.00

1.0

1.2

—

Amiodarone users

0.00

0.0

1.3

—

Kidney transplant status

0.00

0.0

1.0

—

Varicose veins of other sites

0.00

0.0

1.0

—

Cardiomyopathy, other and unspecified

0.00

0.0

1.3

—

Other diseases of arteries and capillaries

0.00

0.0

1.0

—

Pustulosis palmaris et plantaris

0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

0.0

1.0

—

Pleural plaque

0.00

0.0

1.3

—

Ménière disease

0.00

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.0

1.2

—

Sicca syndrome [Sjögren]

0.00

0.0

1.1

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

1.0

—

Corns and callosities

0.00

0.0

1.0

—

Intestinal malabsorption

0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

0.0

1.0

—

Mandibular retrognathia

0.00

0.0

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.0

1.1

—

Other infective otitis externa

0.00

0.0

1.0

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

0.0

1.3

—

Myeloproliferative diseases

0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

0.0

1.1

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.3

—

Other osteochondropathies

0.00

0.0

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

1.0

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

0.00

0.0

1.0

—

Other necrotizing vasculopathies (FG)

0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

Other obstetric trauma

0.00

0.0

1.5

—

Crohn disease (strict definition, require KELA)

0.00

0.0

1.1

—

Postpartum haemorrhage due to anatomy

0.00

0.0

1.4

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Crohn's disease of large intestine

0.00

0.0

1.2

—

Diffuse large B-cell lymphoma

0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

0.0

1.4

—

Benign neoplasm of major salivary glands

0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.2

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ethylene glycol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS